UNSPSC 51434957: Reserpine/trichlormethiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434957 Reserpine/trichlormethiazide, a Commodity code, does not align with the state and local procurement activity currently posted under it. The City of Tampa's Fire Rescue department is soliciting Advanced Life Support Medications through an IFB (sealed bid), but the medications specified—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—are emergency cardiac and cardiovascular drugs bearing no relation to reserpine (an antihypertensive) or trichlormethiazide (a diuretic). The code appears to have been applied incorrectly to this opportunity, or the taxonomy entry does not reflect actual state and local emergency medical purchasing patterns. No additional recent opportunities under this code are present in the source.

The single visible opportunity, City of Tampa Solicitation 26P00188, closed April 8, 2026, with an estimated contract value of $40,000 and award within 120 days of bid opening. The contract term is one year with two one-year renewal options and up to three additional 30-day unilateral extensions. The IFB includes a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation (not to exceed $10,000) and requires vendors to supply medications with nine-month minimum expiration dates, delivery within ten calendar days, and full-year warranty coverage. All bids were to be submitted electronically through OpenGov eProcurement Portal. Given the mismatch between the code's nominal scope and the actual solicitation, this Commodity code shows little relevant recent activity for business development purposes.